MedTrace Logo

Evaluation of TEG 6S PM® During Cardiopulmonary Bypass to Detect Postoperative Biological Coagulopathy

NCT06230640 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 60

Last updated 2025-03-12

No results posted yet for this study

Summary

This is a prospective study to evaluate the predictive value of the TEG 6s platelet mapping® (TEG 6s® PM) performed during cardiopulmonary bypass (CPB) in the prediction of biological coagulopathy (determined by TEG 6S global hemostasis®), in cardiac surgery with high risk of bleeding.

Conditions

  • Coagulopathy
  • Cardiopulmonary Bypass
  • Cardiac Surgery

Interventions

DIAGNOSTIC_TEST

In vitro medical diagnostic device TEG6s® Platelet Mapping

Preoperative period: * Pre-operative blood sampling, according to the usual practices of the unit before surgery * Collection of the patient's usual demographic characteristics per operative period : * After anesthetic induction:a TEG6S platelet mapping® sampled from the arterial catheter routinely placed after anesthetic induction * During the CPB, 30 min before aortic declamping: performing TEG 6S platelet mapping® (heparinized tube) * 5 min after heparin antagonization by protamine, after the weaning of the bypass, and before any transfusion: performing a TEG 6S citrate® (citrated tube) Post-operative period (resuscitation): • postoperative bleeding at 2 hours and during the first 12 hours.

Sponsors & Collaborators

  • University Hospital, Montpellier

    lead OTHER

Principal Investigators

  • Benjamin Bourdois, MD · University Hospital, Montpellier

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-07-01
Primary Completion
2025-03-10
Completion
2025-03-10

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06230640 on ClinicalTrials.gov